Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on August 17, 2021, regarding events occurring on August 13, 2021. The filing discloses an executive appointment and associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details:
- Annual Base Salary: $350,000
- Annual Bonus Opportunity: Up to $200,000 (contingent on performance measures)
- Stock Options Granted: 95,000 options
- Option Exercise Price: $3.00 per share
Material Changes
On August 13, 2021, the Board of Directors appointed Ryan Polley as Chief Operating Officer (COO). Mr. Polley previously served as Chief Product and Strategy Officer for the company since March 2020. This appointment represents a change in senior management structure and compensation obligations.
Outlook, Risks, and Unusual Items
Management Commentary and Compensation Structure:
- Performance Metrics: The 2021 bonus is tied to new product revenue goals and technology expense initiatives.
- Vesting Schedule: Options vest over four years (25% on the first anniversary, with the remainder vesting quarterly).
- Change in Control: 100% of the granted options become vested and nonforfeitable upon a Change in Control.
Risks and Contingencies: The filing does not disclose specific operational risks or contingencies beyond the standard vesting conditions tied to continued employment.
Key Facts for Investor Verification
- Verify the impact of the new COO appointment on the company's strategic direction regarding new product revenue.
- Confirm the dilution impact of the 95,000 stock options granted at an exercise price of $3.00.
- Review the specific performance targets for "new product revenue" and "technology expense initiatives" to assess bonus payout likelihood.
- Monitor the company's stock price relative to the $3.00 exercise price to evaluate the intrinsic value of the granted options.